Beacon at a glance

Beacon Pharmaceuticals PLC is one of the leading and fastest-growing pharmaceutical companies in Bangladesh. Beacon was the first company in Bangladesh to introduce anticancer drugs and has been leading the Bangladesh oncology market for a decade. The company was established in 2006 and started commercial production in 2009 with a vision of caring for global patients by providing innovative and advanced new drugs at an affordable price. Beacon started its operation as a private limited company and transformed into a public limited company in 2010.

Currently, around 5000 employees work at Beacon, including a group of talented pharmacists, engineers, chemists, and microbiologists. The company manufactures more than 400 generic pharmaceutical products and over 140 anti-cancer drugs. The company manufactures all these products in four dedicated GMP-compliant facilities, including the Oral & Solid Facility, Parenteral Production Facility, Oncology Facility, and Cephalosporin and Penem Facility. The Cephalosporin facility is accredited by EU GMP. All the facilities are located in Bhaluka, Mymensingh, 10 km north of Dhaka city, and were designed by European consultants.

After meeting local demand, the company started exporting its products. Patients in 135 countries are using Beacon’s products, and Beacon has its own sales and marketing operations in 17 countries.

Beacon has advanced R&D labs where the latest drugs are developed by a group of talented pharmacists. Beacon has become globally popular for its 31 global first generic products, which were introduced after the originator products.

Key Highlights

  • A decade in caring for global cancer and hepatitis patients.

  • Manufacturing more than 400 generic drugs including Anticancer, Diabetes, Cardiovascular, Antibiotics, Anti-coagulant, Protein and Vitamin supplements, Muscle relaxant, NSAID etc.

  • 4 State-of-the-art GMP-compliant facilities.
  • Cephalosporin plant is approved by EU-GMP.
  • Patients from 135 countries are using Beacon’s products.
  • Globally popular for its 31 global first generic.

Guiding Principles

beacn manufacturer